Related Experiment Video

Updated: Mar 29, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

13.1K

Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and

Lindsey E Romick-Rosendale1, Elizabeth E Hoskins1, Lisa M Privette Vinnedge1

  • 1Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Abstract

Insights

Loss of Fanconi anemia (FA) pathway genes in head and neck squamous cell carcinoma (HNSCC) promotes cell invasion. This invasive behavior is driven by DNA-PK and Rac1 signaling, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Head and neck squamous cell carcinoma (HNSCC) is a significant cause of cancer mortality.
  • Invasive tumor behavior in HNSCC correlates with poor patient outcomes.
  • The molecular pathways driving HNSCC invasion are not fully understood.

Purpose of the Study:

  • To investigate the phenotypic and molecular effects of Fanconi anemia (FA) pathway loss in HNSCC.
  • To identify genetic pathways and molecular mechanisms underlying advanced HNSCC phenotypes.

Main Methods:

  • Utilized HNSCC cell lines with and without FA gene knockdown.
  • Confirmed FA pathway inactivation via DNA cross-linker sensitivity.
  • Performed RNA sequencing, qRT-PCR, and invasion assays with specific inhibitors (DNA-PK, Rac1).

Main Results:

  • FA loss induced cytoskeletal changes and increased HNSCC cell invasion without affecting proliferation.
  • Cellular invasion due to FA loss was partly mediated by DNA-PK and Rac1 activity.
  • Identified a link between FA pathway deficiency and enhanced tumor cell motility.

Conclusions:

  • Fanconi anemia pathway loss significantly enhances HNSCC cell motility and invasion.
  • A targetable DNA-PK/Rac1 signaling axis is implicated in FA-deficient HNSCC.
  • These findings suggest potential therapeutic strategies for advanced HNSCC.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression02:07

Tumor Progression

3.6K